PMID- 16467141 OWN - NLM STAT- MEDLINE DCOM- 20060613 LR - 20240412 IS - 0027-8424 (Print) IS - 1091-6490 (Electronic) IS - 0027-8424 (Linking) VI - 103 IP - 8 DP - 2006 Feb 21 TI - In search of rat stem Leydig cells: identification, isolation, and lineage-specific development. PG - 2719-24 AB - Leydig cells (LCs) are thought to differentiate from spindle-shaped precursor cells that exhibit some aspects of differentiated function, including 3beta-hydroxysteroid dehydrogenase (3betaHSD) activity. The precursor cells ultimately derive from undifferentiated stem LCs (SLCs), which are postulated to be present in testes before the onset of precursor cell differentiation. We searched for cells in the neonatal rat testis with the abilities to: (i) proliferate and expand indefinitely in vitro (self renew); (ii) differentiate (i.e., 3betaHSD and ultimately synthesize testosterone); and (iii) when transplanted into host rat testes, colonize the interstitium and subsequently differentiate in vivo. At 1 week postpartum, spindle-shaped cells were seen in the testicular interstitium that differed from the precursor cells in that they were 3betaHSD-negative, luteinizing hormone (LH) receptor (LHR)-negative, and platelet-derived growth factor receptor alpha (PDGFR alpha)-positive. These cells were purified from the testes of 1-week-old rats. The cells contained proteins known to be involved in LC development, including GATA4, c-kit receptor, and leukemia inhibitory factor receptor. The putative SLCs expanded over the course of 6 months while remaining undifferentiated. When treated in media that contained thyroid hormone, insulin-like growth factor I, and LH, 40% of the putative SLCs came to express 3betaHSD and to synthesize testosterone. When transplanted into host rat testes from which LCs had been eliminated, the putative SLCs colonized the interstitium and subsequently expressed 3betaHSD, demonstrating their ability to differentiate in vivo. We conclude that these cells are likely to be the sought-after SLCs. FAU - Ge, Ren-Shan AU - Ge RS AD - Population Council, 1230 York Avenue, New York, NY 10021, USA. FAU - Dong, Qiang AU - Dong Q FAU - Sottas, Chantal M AU - Sottas CM FAU - Papadopoulos, Vassilios AU - Papadopoulos V FAU - Zirkin, Barry R AU - Zirkin BR FAU - Hardy, Matthew P AU - Hardy MP LA - eng GR - R01 HD033000/HD/NICHD NIH HHS/United States GR - HD-33000/HD/NICHD NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural DEP - 20060208 PL - United States TA - Proc Natl Acad Sci U S A JT - Proceedings of the National Academy of Sciences of the United States of America JID - 7505876 RN - 0 (Receptors, LH) RN - 0 (Thyroid Hormones) RN - 67763-96-6 (Insulin-Like Growth Factor I) RN - 9002-67-9 (Luteinizing Hormone) RN - EC 1.1.- (3-Hydroxysteroid Dehydrogenases) RN - EC 2.7.10.1 (Receptor, Platelet-Derived Growth Factor alpha) SB - IM MH - 3-Hydroxysteroid Dehydrogenases/analysis/*metabolism MH - Animals MH - Cell Differentiation MH - *Cell Lineage MH - Insulin-Like Growth Factor I/pharmacology MH - Leydig Cells/chemistry/*cytology/drug effects MH - Luteinizing Hormone/pharmacology MH - Male MH - Rats MH - Receptor, Platelet-Derived Growth Factor alpha/analysis MH - Receptors, LH/analysis MH - Stem Cell Transplantation MH - Stem Cells/chemistry/*cytology/drug effects MH - Testis/cytology MH - Thyroid Hormones/pharmacology PMC - PMC1413776 COIS- Conflict of interest statement: No conflicts declared. EDAT- 2006/02/10 09:00 MHDA- 2006/06/14 09:00 PMCR- 2006/02/21 CRDT- 2006/02/10 09:00 PHST- 2006/02/10 09:00 [pubmed] PHST- 2006/06/14 09:00 [medline] PHST- 2006/02/10 09:00 [entrez] PHST- 2006/02/21 00:00 [pmc-release] AID - 0507692103 [pii] AID - 1134 [pii] AID - 10.1073/pnas.0507692103 [doi] PST - ppublish SO - Proc Natl Acad Sci U S A. 2006 Feb 21;103(8):2719-24. doi: 10.1073/pnas.0507692103. Epub 2006 Feb 8.